Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 cases
Emily M. Eichenberger(Emory University), Cameron R. Wolfe(Duke Medical Center), Jacob A. Klapper(Duke Medical Center), Philip J. Spencer(Mayo Clinic), Carolyn Glass(Buck Institute for Research on Aging), Amanda C. Coniglio(Duke University), Louis R. DiBernardo(Duke Medical Center), Carmelo A. Milano(Duke University Hospital), Jacob N. Schroder(Duke University), Elizabeth N. Pavlisko(Duke Medical Center), Chetan B. Patel, Adam D DeVore(Duke University), Benjamin S. Bryner(Northwestern University), John C. Haney(Duke Medical Center), John M. Reynolds(Alfred Health)
Cited by 36
Related Papers
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
|Clinical Microbiology Reviews|2015|5.1k
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
|Nature Reviews Microbiology|2019|2k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583